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ABSTRACT:		9	
The	growth	of	importance	of	nanocapsules	(and	other	particulate	systems)	in	different	fields	requires	fast	10	
and	reproducible	methods	 for	 their	production.	Confined	 impinging	 jet	mixers	were	successfully	used	 for	11	
the	production	of	nanospheres	and	are	now	tested	for	the	first	 time	for	the	production	of	nanocapsules.	12	
This	work	focuses	on	the	understanding	of	formation	mechanisms	and	on	the	quantification	of	the	effect	of	13	
the	most	important	operating	parameters	involved	in	their	production.	Solvent	displacement	is	employed	14	
here	for	the	assembly	of	the	nanocapsules	by	using	a	PEGylated	derivative	of	cyanoacrylate	as	copolymer.	15	
A	 comparison	with	 nanospheres	 obtained	 under	 the	 same	operating	 conditions	 is	 also	 reported.	 Results	16	
show	that	the	oil-to-copolymer	mass	ratio	(MR)	 is	the	main	factor	affecting	the	final	size	distribution	and	17	
that	small	nanocapsules	are	obtained	only	at	 low	oil-to-copolymer	MR.	The	effect	of	mixing	 is	significant,	18	
proving	that	mixing	of	solvent	and	antisolvent	also	affects	the	final	size	distribution;	this	depends	mainly	on	19	
the	inlet	jet	velocity,	but	the	size	of	the	mixer	is	also	important.	The	Reynolds	number	may	be	useful	to	take	20	
this	 into	 account	 for	 geometrically	 similar	 systems.	 Quenching	 by	 dilution	 allows	 to	 stabilize	 the	21	
nanocapsules,	evidencing	the	role	of	aggregation	and	ripening	22	
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INTRODUCTION 29	
In the last years, the pharmaceutical interest in nanotechnology has widen because of the 30	
possibilities it offers in releasing drug molecules, enhancing their therapeutic activity, reducing side 31	
effects, and increasing the lifetime of the drug in vivo. Different nanocarriers have been 32	
investigated, namely, liposomes, solid lipid particles, microparticles, and nanoparticles based on 33	
synthetic or natural polymers. Polymer nanoparticles include polymeric nanospheres and polymeric 34	
nanocapsules. In nanospheres, the drug is incorporated in the polymeric matrix, whereas polymeric 35	
nanocapsules have an inner liquid core surrounded by a polymeric layer, so that a large variety of 36	
drugs can be dissolved in the inner core, according to their solubility. The drug molecules inside the 37	
nanospheres are generally dispersed in the polymer matrix in a sort of solid solution but may also 38	
form a solid core coated by the polymer, whereas in nanocapsules they are dissolved in the liquid 39	
core; as a consequence, drug release occurs according to different mechanisms in nanospheres and 40	
nanocapsules. It depends on biodegradation and bioerosion of the polymer by enzymes and on drug 41	
diffusivity through the polymeric matrix, in the case of nanospheres, whereas in nanocapsules it 42	
depends also on the partitioning between the media inside and outside the polymeric shell.1 In 43	
comparison to nanospheres, nanocapsules need a lower amount of polymer and can be loaded with 44	
larger amounts of drug, depending on the drug solubility in the inner liquid.2 This work focuses on 45	
polymeric nanocapsules for pharmaceutical applications, but nanocapsules find wide use also in the 46	
cosmetic and agrochemical fields. The wide growth of their application requires innovative methods 47	
for faster production; the use of micromixers is here investigated for the first time. 48	
Polymers from the family of poly(alkyl cyanoacrylates) (PACA) have been extensively used for the 49	
preparation of drug carriers. PACA nanoparticles are very common, thanks to their ability to 50	
achieve tissue targeting and enhance the intracellular penetration of drugs.3 The amphiphilic 51	
copolymer poly(methoxy polyethylene glycol cyanoacrylate-co-hexadecyl cyanoacrylate)4, 52	
indicated as poly(MePEGCA-co-HDCA) in what follows, is used in this work. This kind of 53	
copolymer allows to obtain “stealth” nanocapsules, thanks to the polyethylene glycol (PEG) chains. 54	
In fact, a limit of standard polymer nanoparticles, without PEG chains, is that in vivo opsonins 55	
adsorb onto their surface and then nanoparticles can be recognized by macrophages and can be 56	
accumulated in liver and spleen. A PEG coating increases their blood lifetime because it creates an 57	
aqueous shell around the nanoparticle, which avoids opsonin adsorption and the subsequent 58	
macrophage uptake. 59	
Polymer nanocapsules, as well as nanospheres, can be prepared both by polymerization 60	
methods5,6and from preformed polymer, by different mechanisms such as, for example, solvent 61	
displacement,7emulsion–diffusion,8 double emulsification,9 and so on. The different processes and 62	
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the characteristics of the nanocapsules produced have been recently compared.10 In solvent 63	
displacement methods (also called interfacial deposition or flash nanoprecipitation), the polymer is 64	
prepared in a previous step, resulting in some advantages with respect to interfacial polymerization. 65	
In fact, solvent displacement allows to use polymers with controlled molecular weight, avoids the 66	
presence of residual monomers in solution, it is simpler and more reproducible, and it is easier to 67	
scale-up. Solvent displacement consists of mixing a water-miscible organic phase, containing the 68	
polymer, the oil, and generally the drug, with an aqueous phase. The organic phase is referred to as 69	
solvent, whereas water is the antisolvent. When the two phases are mixed together, the organic 70	
phase diffuses rapidly into the water, where it is soluble and where on the contrary the polymer, the 71	
oil, and the drug are insoluble. The rapid diffusion of the solvent in the antisolvent is the driving 72	
force in nanocapsules formation, inducing oily drops formation and the interfacial deposition of the 73	
polymer around the oily drops. 74	
The overall process being very rapid, it is influenced by mixing and in order to obtain good mixing 75	
conditions, special micromixers must be used. Confined impinging jet mixers (CIJMs) provide 76	
optimum mixing conditions. Their use in nanosphere formation was extensively studied11–13 and 77	
they were found to be very useful in controlling the final particle size.14 CIJMs consist of two high 78	
velocity linear jets of fluid that collide inside a small chamber, whose size affects the overall mixing 79	
rate. 80	
Mixing mechanism and nanoparticle formation in CIJMs, similar to the ones studied in this work, 81	
were analyzed in previous papers through computational fluid dynamics (CFD) 82	
simulations.15,16 CFD simulations allow to quantify the mixing dynamics of the two inlet streams 83	
inside the mixing chamber. Three types of mixing mechanisms are generally present: macromixing 84	
at the mixer scale, mesomixing at the scale of the largest turbulent eddies, and micromixing at the 85	
molecular scale. Each step controls the next one and can be rate limiting. CIJMs limit the 86	
mesomixing time and ensure fast homogenization (i.e., short macromixing time) of the two fluids. 87	
Characteristic global mixing times in these equipments were calculated by CFD and are in the order 88	
of magnitude of milliseconds.17,18 89	
In this work, the use of the CIJMs for the production of polymer nanocapsules suitable for 90	
pharmaceutical applications is investigated for the first time. As the mechanisms of nanocapsule 91	
formation are likely different from those of nanospheres, we are particularly interested in 92	
investigating the interplay between mixing and nanocapsules formation, with the precise scope of 93	
highlighting similarities and differences. Attention is paid to the control of nanocapsule size 94	
distribution. In fact, different applications translate into different requirements. For example, in the 95	
case of intravenous administration, nanocapsules have to be smaller than 300 nm. For other 96	
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applications, such as cosmetic19 and food,20 size limitations are different; therefore, the 97	
development of strategies to control the final nanocapsule size turns out to be very useful. Our work 98	
aims also at understanding if mixing can be used (also for nanocapsule) as an active parameter to 99	
control and tune the final size distribution. 100	
It should be highlighted that no drug has been considered in this work. Although in the case of 101	
nanospheres, the absence or the presence of the drug can significantly alter the results (and can 102	
modify the particle structure), especially in terms of stability (as shown, for example, for 103	
doxorubicin-loaded polymer nanospheres21), in the case of nanocapsules, the situation seems to be 104	
very different, representing yet another difference between the two systems. In fact, the oil 105	
separates from the initial single-phase system through spinodal decomposition; no energetic barrier 106	
has to be overcome (as dictated by the Cahn–Hilliard equation) and molecular diffusion is the 107	
bottleneck. As the drug is generally hydrophobic and in low concentration (in comparison with the 108	
oil), drug molecules will likely move rapidly inside the oily drops. Indeed, a successive study with a 109	
drug is required to prove this last point and this simpler oil–polymer system will be used as 110	
reference. 111	
 112	
	113	
THEORETICAL BACKGROUND 114	
The formation of nanocapsules and nanospheres during solvent displacement is a complex process 115	
and many theories and interpretations have been presented in the literature. Knowledge of what 116	
happens at the molecular level is of primary importance for manipulating and controlling the overall 117	
process. Classical precipitation theory explains particle formation in three steps: nucleation, 118	
molecular growth, and particle aggregation.22 Supersaturation is the driving force for particle 119	
formation and in solvent displacement processes, it is built up by mixing of the solvent and the 120	
antisolvent. As in this work we are interested in both nanospheres and nanocapsules, it is necessary 121	
to review and briefly discuss the theory presented in the literature for these two systems. 122	
In the case of nanospheres, the copolymer and organic compound are dissolved in the solvent and 123	
when mixed with the antisolvent, particles are formed. Johnson and Prud'homme23 describe 124	
nanosphere formation as the competition of two simultaneous phenomena: nucleation of drug 125	
particles and copolymer self-assembly. The two phenomena are characterized by different time 126	
scales and in order to allow the copolymer molecules to interact with (and to deposit on) the 127	
growing particles, the two time scales have to match one another. Typical operating conditions, 128	
used in the production of most of the organic drug particles, are characterized by extremely high 129	
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supersaturation, resulting in very small nucleus size, practically instantaneous nucleation, with very 130	
little energy barrier. It is also important to compare these time scales with the mixing time scale. It 131	
was in fact observed that faster mixing generally results in smaller drug particles with higher 132	
functionalization by the copolymer; however, once a certain limit is reached, no significant change 133	
in nanoparticle properties is observed. This is probably related to the development of a spatially 134	
independent self-similar state caused by the achievement of fully turbulent flow. 135	
In the case of nanocapsules, the inner core of the particle consists instead of a lipophilic liquid 136	
(usually oil), which is insoluble in the mixture of solvent and antisolvent. Thus, in nanocapsule 137	
formation, two phenomena are involved: oily drop formation and polymer deposition around the 138	
oily drop. Oily drop formation takes place through spinodal decomposition (as dictated by the 139	
Cahn–Hilliard equation). Therefore, although due to the high supersaturation the nucleation process 140	
involved in nanosphere formation generates a very small energy barrier, some differences between 141	
nanospheres and nanocapsules, where on the contrary spinodal decomposition occurs spontaneously 142	
without any energy barrier, might be observed. 143	
In addition, when solvent and antisolvent are mixed together, the oil dissolved in the solvent 144	
separates, resulting in drops which tend to coalesce. This can be prevented (as in the case of 145	
nanospheres) by the deposition of the copolymer around the drops; however, in the case of 146	
nanocapsules, copolymer reorientation on the interface might play a different role. In any case, also 147	
for nanocapsules, mixing efficiency is expected to be fundamental in order to have homogeneous 148	
and optimal conditions for the formation of very small drops and an even distribution of copolymer 149	
molecules around drops. 150	
Some authors24,25 have acknowledged the important contribution of the Gibbs–Marangoni effect 151	
on the formation of nanocapsules, in which the driving force is the difference in the interfacial 152	
tension between the solvent and the antisolvent. This effect is not considered in this work because it 153	
is important when nanocapsules are produced with the classical method, adding slowly the solvent 154	
to the aqueous phase. Using micromixers, such as CIJMs, under very intense turbulent mixing 155	
conditions, this effect is expected to be less important. 156	
 157	
MATERIALS AND METHODS 158	
The poly(MePEGCA-co-HDCA) copolymer was synthesized by condensation of the two monomers 159	
(MePEG cyanoacetate and n-hexadecyl cyanoacetate) in ethanol and dichloromethane. The ratio 160	
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between MePEG cyanoacetate/hexadecyl cyanoacetate was 1:4. The synthesis was carried out under 161	
the presence of formaldehyde and dimethylamine, as described in another work,17 following the 162	
procedure of Peracchia et al.,26 with some minor changes. 163	
The copolymer was characterized in terms of its molecular weight, by using dynamic light 164	
scattering (DLS) and by resorting to the Debye theory, by differential scanning calorimetry and 165	
by 1H NMR.17 DLS characterization resulted in a molecular weight of about 4.37 kDa, whereas the 166	
two other characterizations confirmed the presence of the two monomers (the lipophilic one, 167	
HDCA, and the hydrophilic one, MePEGCA) and their approximate ratio of 1:4. 168	
In all the experiments, Miglyol® 812N (a mixture of capric and caprylic acid) was used as liquid 169	
core (courtesy of Sasol Italy S.p.A). The solvent is Acetone Chromasolv (high-performance liquid 170	
chromatography grade), purchased by Sigma–Aldrich Italia (Milano). Milli-Q RG system by 171	
Millipore® (Billerica, MA, USA) was used to produce the ultrapure water employed in all the 172	
experiments. 173	
Nanocapsules and nanospheres were prepared by solvent displacement. In nanocapsule 174	
precipitation, the copolymer together with Miglyol® was dissolved in acetone and then mixed with 175	
pure water, whereas in nanospheres, only the copolymer was dissolved in the solvent. Apart from 176	
this, the two preparations were identical. After mixing with water, the particulate system was 177	
immediately formed. As already mentioned, since the process is strongly influenced by mixing, 178	
CIJMs were used that ensure high turbulence levels and short mixing times. Precipitation was 179	
carried out with and without quenching, in order to highlight the possible influence of aggregation; 180	
to this purpose, the outlet of the mixer (8 mL containing equal volumes of acetone and water) was 181	
collected in a beaker containing 4 mL of water. Tests have been carried out in order to identify the 182	
best quenching volume ratio. When this is too small, it could be ineffective in stabilizing the system 183	
but when this is too large, it makes it impossible to use the sample for further characterization 184	
(unless extensive and therefore extremely time-consuming water evaporation is carried out). Four 185	
milliliters of water (corresponding to a 1:2 acetone–water final ratio in the mixture) was found to be 186	
a good trade-off, as quenching with larger volumes did not result in significantly different data, still 187	
resulting in reasonable final nanocapsule concentration. 188	
The solubility of the copolymer for three water–acetone mixtures was studied. The investigated 189	
water volume fractions were 0.5, 0.66 (equivalent to 2/3), and 0.9, corresponding to the three 190	
conditions used in our experiments. In fact, samples without quenching result in mixtures of 0.5, 191	
whereas in quenched samples, the water is twice the acetone, resulting in 2/3. The last condition 192	
corresponds to a sample wherein the largest part of the acetone has been removed. These 193	
experiments were performed at 30°C. 194	
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In our laboratory set up, solvent solution and antisolvent were loaded into two different plastic 195	
syringes of 100 mL of volume and fed into the mixers by using a syringe pump (KDS200, KD 196	
Scientific, Holliston, MA, USA). The pump was calibrated in order to make sure that the imposed 197	
flow rate (FR) was actually delivered. Then, the solvent was removed by a rotating low-pressure 198	
evaporative device (Stuart® Rotary Evaporators). The possible azeotrope for the acetone–water 199	
mixture is in the acetone-rich region; therefore, complete removal of acetone is possible (as the 200	
starting point is an already water-rich solution). The effect of acetone removal on nanocapsules was 201	
quantified and found to be within the range of experimental uncertainty. Stability of the 202	
nanocapsule size after solvent removal was monitored by storing samples at 4°C for several weeks 203	
and measuring the nanocapsule size at regular time interval. No significant size changes were 204	
detected. 205	
Four different CIJMs were used in this work. They all are similar but are characterized by different 206	
size of the inlet and outlet pipe and of the mixing chamber. A sketch is reported in Figure 1, 207	
whereas the detailed quotes are reported in Table 1. They are labeled in what follows as scale-down, 208	
CIJM-d1, scale-up (corresponding to three CIJMs exactly scaled-up by a geometric factor equal to 209	
two), and CIJM-d2 (corresponding to the same chamber size of CIJM-d1 but with bigger inlet pipe). 210	
The comparison of the results obtained with these four mixers allows to evidence scale-up and 211	
scale-down effects, as well as the effect of the chamber and inlet pipe size on the final size 212	
distribution. 213	
Nanocapsules and nanospheres were characterized in terms of their size distribution (although 214	
reported data refer only to the mean size) and zeta potential and spherical shape was confirmed by 215	
Field Emission Scanning Electron Microscope (FESEM) pictures. The size of nanocapsules was 216	
determined by DLS (DLS, Zetasizer Nanoseries ZS90, Malvern Instrument, Worcestershire, UK) 217	
that measures accurately in the size range from 2 nm to 3 µm. Zetasizer Nanoseries ZS90 does not 218	
use a movable detector but uses classical fixed detection arrangement at 90° to the laser and the 219	
center of the cell area. In DLS measurements, the intensity size distribution is converted by using 220	
the Mie theory to a volume size distribution. In order to obtain the volume size distribution, it is 221	
necessary to provide the instrument the refractive index of the material (which does not 222	
significantly influence the final result of the measurement) and of the dispersant. Before measuring, 223	
the sample was diluted to 1:100 in order to reduce the solid concentration. In DLS, it is important to 224	
have a sample with appropriate particle concentration; in fact, it has not to be too concentrated 225	
because each single photon should be scattered only once before reaching the detector, but it has to 226	
be concentrated enough to result in sufficient statistics. The parameters which assure the quality of 227	
the measurements (i.e., polydispersion index, correlation function parameter) were controlled for 228	
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each single sample and measurements were repeated when the quality criteria were not reached. 229	
Each sample was measured three times and the average value is reported in the figures. Thus, in the 230	
following figure, z-average values are reported. 231	
The surface charge of nanoparticles was inferred through zeta potential measurements in water, by 232	
the same instrument, after dilution (1:10). In zeta potential measurements, the instrument measures 233	
the electrophoretic mobility, which is the velocity of a particle in an electric field. The zeta potential 234	
is then calculated from the Henry equation that makes use of the Smoluchowski approximation, 235	
valid for particles in aqueous samples. 236	
All the experiments were performed after dissolving the copolymer and the oil in the acetone. No 237	
stabilizing agent was added to the aqueous phase as the PEGylated polymer can act as a stabilizer 238	
due to its amphiphilic nature. 239	
In order to investigate the interplay between mixing and nanocapsule formation, experiments were 240	
carried out in a wide FR range up to 120 mL/min for both solutions. Results from our previous 241	
work17show that under these conditions, the mixers work under different fluid dynamics regimes. 242	
In fact, the flow is highly turbulent only at the highest FRs (larger than 40 mL/min for the smallest 243	
mixers and larger than 90 mL/min for the biggest mixers) and is instead transitional for the lowest 244	
FRs. In all cases, however, the outlet stream is well mixed, as also at relatively low FRs, good 245	
mixing performances are generally obtained. The reason for investigating the performance of these 246	
devices also at low FRs, when the flow is not fully turbulent, is to verify the possibility of using 247	
mixing as an operating parameter to control the final nanocapsule size. 248	
In these experiments, the acetone solution contained 6 mg/mL of copolymer and 8 µL/mL of oil 249	
(7.6 mg/mL), equivalent to an oil-to-copolymer mass ratio (MR) value of MR = 1.26. We 250	
performed the experiments both with and without quenching to understand the mechanism of 251	
nanocapsule formation and the main differences with respect to nanospheres. In same cases, 252	
experiments were repeated three times in order to quantify the experimental variability, reported 253	
together with the data in the form of error bars. 254	
The effect of oil concentration on nanocapsule size was studied at four different oil concentrations: 255	
0 (i.e., nanospheres), 4.8 µL/mL (4.56 mg/mL), 8 µL/mL (7.6 mg/mL), and 15 µL/mL (14.25 256	
mg/mL) with 6 mg/mL of copolymer concentration. The respective oil-to-copolymer MR was 0.76, 257	
1.26, and 2.37. These experiments were performed in all the CIJMs. Moreover, the same 258	
experiments were performed in the CIJM-d1, varying the copolymer concentration (10, 6, and 3.2 259	
mg/mL). In this case, the oil concentration was kept constant at 8 µL/mL; in this way, the oil-to-260	
copolymer MR was the same of the previous experiments (0.76, 1.26, and 2.37). 261	
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A further set of experiments, keeping constant the oil-to-copolymer mass ratio (MR), was also 262	
carried out. In this case, both copolymer and oil concentrations varied in order to check if it resulted 263	
in nanocapsules with similar size. The two MRs considered were 0.76 (with the following different 264	
concentrations: 4 mg/mL copolymer and 3.2 µL/mL oil, 6 mg/mL copolymer and 4.8 µL/mL oil, 10 265	
mg/mL copolymer and 8 µL/mL oil) and 2.37 (3.2 mg/mL copolymer and 8 µL/mL oil, 6 mg/mL 266	
copolymer and 15 µL/mL oil). This set of experiments was carried out only in CIJM-d1 mixer. 267	
Both the FR and the inlet diameter (din) of the mixer were varied in the experiments resulting in 268	
different mixing regimes inside the device. FR, velocity of the inlet jet (vj), and din are related 269	
through the following relationship: 270	
(1) 271	
At the same FR, the fluid velocity is different in different mixers, resulting in different mixing 272	
efficiencies. According to Johnson and Prud'homme,27 the overall mixing time (τmix) can be 273	
calculated as follows: 274	
(2) 275	
when the flow is fully turbulent and, of course, different mixers are characterized by different 276	
residence times: 277	
(3) 278	
where τres is the residence time and VM is the volume of the mixer. 279	
 280	
RESULTS AND DISCUSSION 281	
Solubility tests revealed that the polymer residual concentration in the water–acetone mixture is 282	
significant when there is an equal amount of water and acetone and this amount slightly decreases 283	
when the water amount increases. A reduction in residual solubility is in fact detected when almost 284	
all the acetone (90%) is removed. Results are summarized in Table 2. This suggests that during 285	
acetone removal, additional polymer molecules can deposit on already formed nanocapsules and 286	
nanospheres. However, this amount does not significantly impact on the final particle size, as size 287	
measurements performed before and after removal (data not shown) highlighted very limited 288	
variations. 289	
Nanocapsule formation was firstly investigated by comparing different mixers and different FRs 290	
(with and without quenching) and subsequently by comparing different initial compositions 291	
(copolymer and oil concentration). Results for the three CIJMs geometrically similar are reported in 292	
Figure 2. The figure shows the zeta potential and the mean particle size for nanocapsules prepared 293	
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with an acetone solution of 6 mg/mL of copolymer and 8 µL/mL of oil (resulting in MR = 1.26) at 294	
different FR values, with and without quenching. 295	
Let us first highlight the effect of the quenching water; if nanocapsules are not quenched, their final 296	
mean size (after solvent evaporation) is significantly larger; this general behavior will be observed 297	
in all the cases investigated, and will be discussed as follows. 298	
A common trend for all the mixers can be observed: increasing the FR, faster mixing is achieved, 299	
resulting in smaller particles. It is also interesting to observe that it is the same for both the 300	
quenched and the nonquenched particles. The data seem to evidence a point after which further 301	
increases in FR has little effect; this is expected by previous works in similar fields. The goal of 302	
using special intensive mixers (such as the ones used in this work) is to ensure that the mixing time 303	
is fast enough (in comparison with the particle formation time) so that the system can be considered 304	
homogeneous. It is not completely correct to specify a single break point, as in the range 305	
considered; in fact, the size is affected by fluid dynamics in a similar way, but this is true on a 306	
logarithmic scale. The effect of a variation of the inlet FR is strong at low FRs (generally below 20 307	
mL/min), whereas it is very weak at higher FRs, generally larger than 40 mL/min. Results seem to 308	
show that mixing can also be used as an active parameter to control particle size. If one wants 309	
smaller particles, higher FRs (and faster mixing rates) should be used; on the contrary, if one wants 310	
bigger particles, smaller FRs (and slower mixing rates) should be used. This can be done until an 311	
effect of the wideness of the size distribution is detected. As simulations for a similar system show, 312	
in some cases there is a significant effect of mixing on particle size but a very limited one on 313	
polydispersity (especially when this is quantified as relative to the mean particle size). The 314	
combination of these two factors results in the possibility of playing with mixing only for the fine 315	
tuning of particle size, leaving almost unchanged relative polydispersity. 316	
It must be said that at very low FR the uncertainty of the experimental data is relatively high, 317	
especially for the larger mixers, for which a lower reproducibility is observed; this may be a 318	
consequence of the fluid dynamic regime, as the inlet jets are laminar and thus the flow in the 319	
chamber is in the transitional region, with turbulence developing. In any case, it seems that the size 320	
increase that is observed, even when no quench is used, is similar in the whole range investigated, 321	
including the low FR region, thus confirming that the mixing performances of these devices are 322	
good also in the laminar regime. 323	
In Figure 2, the performances of the three mixers are compared plotting the size of the nanocapsules 324	
obtained versus the inlet FR (the FR in each of the two inlets is considered), in order to evidence the 325	
influence of the size of the apparatus at constant throughput. The measured zeta potential is, as 326	
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average, between −30 and −45 mV, indicating that nanocapsules are stable from the electrochemical 327	
point of view. They reach lower values (−40 and −50 mV) if water dilution is carried out. 328	
The scale-down mixer results in the smaller nanocapsules, probably due to the fact that it gives the 329	
best mixing conditions, at fixed FR. As scale-down mixer inlet jet diameter is 0.5 mm, the inlet 330	
stream can reach very high velocities, and as a consequence, high turbulent energy dissipation rates, 331	
and very short mixing times. But the inlet jet velocity is not the controlling variable, as shown in 332	
Figure 3; in fact, it can be noted that comparing the size obtained in the different mixers at the same 333	
inlet velocity, the conclusion is reversed, and the smallest nanocapsules are obtained in the scale-up 334	
mixer, whereas the scale-down mixer gives larger particles (and with higher energy costs). Only the 335	
quenched particle case is shown, but the behavior is similar (at least for the three-scaled mixers) for 336	
the nonquenched case. In these cases, the ratio between the inlet jet diameter and the chamber size 337	
is maintained constant, thus it is not possible to evidence which one of these geometrical variables 338	
eventually is more important, but it may be concluded that a larger size is surely favorable because 339	
it allows to increase throughput, reducing at the same time the final particle size (or eventually to 340	
obtain the same size at reduced jet velocity, and thus with lower energy input). 341	
 342	
It is thus evident that the size of the apparatus plays a more complex role; if the Reynolds number is 343	
used to characterize the fluid dynamic conditions, and thus mixing, it is observed that the curves 344	
corresponding to the three mixers collapse onto a single one. Of course, Reynolds number can take 345	
into account only fluid dynamics similarity and only for geometrically similar devices, thus the 346	
behavior described above is observed only for the three-scaled mixers and for the same inlet 347	
concentrations of oil and polymer (that is for a fixed characteristic process time). 348	
More complex to explain is the behavior of the CIJM-d2, which has the same chamber of the CIJM-349	
d1, but larger inlet pipe diameters, equal to those of the scale-up device; in particular, significant 350	
differences are observed with and without quench. When nanocapsules are quenched, the size of the 351	
particles obtained, at a given FR, is approximately the same in the CIJM-d2 and in the scale-up 352	
mixer. It can be noted that in this case the inlet velocity is also the same, as the pipe diameter is 353	
equal (see also Fig. 3); this would suggest that the jet velocity is more relevant than the chamber 354	
size to determine mixing conditions. On the contrary, at a given jet velocity, smaller particles are 355	
obtained in the CIJM-d2 than in CIJM-d1; this might indicate that, for a given chamber volume, it is 356	
favorable to have a larger interaction zone of the two streams. It can be noted anyway that operating 357	
at the same jet velocity in the two considered mixers requires larger FRs in the one with larger pipe 358	
diameters (the CIJM-d2), and this leads to proportionally shorter residence times; thus, the smaller 359	
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size might be also a consequence of the reduced time for coalescence, and connected to a lower 360	
yield of the process. 361	
If the outlet flow is not quenched, the behavior is different. At a given FR, the CIJM-d2 produces 362	
particles significantly larger than all the others, and in particular larger than the scale-up mixer; 363	
comparing the performances at a given inlet velocity, CIJM-d2 and CIJM-d1 produce nanocapsules 364	
of similar size. The comparison with the scale-up mixer evidences that in this case a larger chamber 365	
is favorable, as it allows to obtain smaller nanocapsules; as suggested by Johnson and 366	
Prud'homme,27what may be relevant is the ratio between the inlet pipe diameter and a characteristic 367	
chamber dimension and this value must not be too large to allow the mixing to be confined within 368	
the chamber. It is possible that in CIJM-d2, the particle formation process is not completed in the 369	
mixer, and this can explain the significant size increase observed in case of nonquenched 370	
nanocapsules; the CFD simulations carried out in a previous work for the same geometry confirm 371	
that the mixing process (at very low FRs) may be not complete.18 This fact may be also responsible 372	
for the larger experimental uncertainty that is observed in the test carried out in the CIJM-d2. 373	
The influence on the mean nanocapsule size of the inlet pipe diameter, for mixers with the same 374	
chamber volume, is shown in Figure 4; in this case, the data are plotted considering the inlet jet 375	
Reynolds number (for an inlet jet with average properties of the mixed liquid streams). It can be 376	
noted that in case of quenched nanocapsules, a unique curve is obtained (and as discussed before, 377	
this is the same curve valid for all the mixers in these concentration conditions), whereas for 378	
nonquenched ones, larger sizes are obtained in the CIJM-d2, as discussed before. Figure 4 allows 379	
also to compare the experimental uncertainty in the case of quenched and nonquenched processes; 380	
in the latter case, it is significantly higher. Zeta potential measurements (not shown) result in values 381	
slightly lower than −30 mV. 382	
 383	
These results show the feasibility of CIJMs for the production of nanocapsules and prove that fast 384	
mixing is needed in order to control nanocapsules size and in order to guarantee high 385	
reproducibility. Better mixing conditions allow the formation of smaller oily drops and a better 386	
coverage by the copolymer, resulting in smaller particles. Moreover, results show that quenching is 387	
an important factor and cannot be avoided if nanocapsules with controlled characteristics are 388	
desired. It may be also concluded that the process can be scaled using the Reynolds number, at least 389	
for geometrically similar devices; the relative size of inlet pipes and chamber has shown to affect 390	
the process, but its influence on final nanocapsule size is complex, and cannot be taken into account 391	
with a simple relationship, such as that proposed for the mixing time in literature.27 Also the 392	
influence of the mixing time will require further work to be quantified in the case of this specific 393	
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application. In fact, the results obtained confirm that process kinetics and mixing interact and when 394	
reducing the mixing time, smaller particles are obtained. However, modifications of the mixer size 395	
and geometry cannot be taken into account simply by the variation in the mixing time estimated in 396	
the different mixing devices, even for the same inlet polymer and oil concentrations. In fact, using 397	
the mixing times estimated by CFD simulations18for the different mixers to correlate the particle 398	
size obtained, it is not possible to obtain a unique curve for the runs obtained in different mixers. 399	
The effect of oil concentration on nanocapsule formation was also investigated. At a constant 400	
copolymer concentration of 6 mg/mL, the oil concentration was varied between zero (resulting in 401	
nanospheres) and a maximum value. Data are collected in Figure 5, where the results obtained for 402	
four different oil-to-copolymer MRs are reported for each mixer; the data are plotted versus the 403	
Reynolds number, on the basis of the results discussed in the previous parts of this work, and as the 404	
experiments were carried out in the same flow rate range for the different mixers, obviously the 405	
extension of the jet Reynolds number range investigated is different. The results confirm that for 406	
every set of concentrations, a single curve is obtained for the different scaled mixers (in fact, the 407	
approximation curve drawn in the different graphs of the figure is this common line), whereas a 408	
behavior similar to that discussed before is observed for the CIJM-d2. These conclusions are 409	
generally valid also for other polymer concentrations, but as it will be shown in the following, for 410	
very low polymer concentrations, the formation of nanocapsules may be difficult. 411	
As a general trend, it is possible to state that decreasing the oil-to-copolymer MR, the mean particle 412	
size decreases. That can be due to the fact that when the oil-to-copolymer MR increases, there is not 413	
enough copolymer to cover a larger surface area, resulting in bigger nanocapsules. 414	
Each experiment at a given oil-to-copolymer MR was repeated with and without quenching water. 415	
Quenching reduces the final nanocapsule size, but the effect is stronger at higher ratios, where there 416	
is a lower amount of copolymer. As already mentioned, the operation of quenching allows to stop 417	
nanocapsule evolution and freeze them as they are immediately after exiting the CIJM. In fact, 418	
quenching dilutes the residual polymer concentration and the particulate system decreasing the 419	
probability of nanocapsule collision and further growth. If we compare the results at different oil-to-420	
copolymer MRs, it is clear that the size increase is more relevant at high MR values, where there is 421	
less copolymer to cover the oily drops. As a matter of fact, the results obtained at MR = 0.76 422	
present a very small difference with or without quenching. This suggests that the copolymer coating 423	
has an important role in stabilizing the suspensions and avoiding nanocapsule aggregation and 424	
coalescence. 425	
In Figure 5 also nanospheres produced under similar operating conditions are shown for 426	
comparison; the size is always much smaller than that obtained in nanocapsules, which is mainly 427	
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determined by the size of the oil drops formed, suggesting that size increase can take place for 428	
further aggregation of copolymer molecules from the solution and not for the collision of the 429	
nanospheres. 430	
In comparison to nanospheres (MR = 0), where there is no oil inside, in nanocapsule, the energy 431	
barrier that has to be overcome due to repulsion forces in case of aggregation seems to be lower due 432	
to the presence of the oil. Thus, the stability of the nanocapsule suspension could be related with the 433	
thickness of the copolymer wall formed. This will surely decrease if the oil-to-copolymer MR is 434	
increased and in the case considered is the largest at MR = 0.76. Moreover, we can assume that 435	
good mixing allows more copolymer to be available for covering oily drops. 436	
As noted in Figure 2, particle size does not significantly change when working with FR values 437	
greater than 40 mL/min. That probably happens because the system reaches good mixing 438	
conditions, which guarantee small particle size. Comparison with the data shown in 439	
Figure 5 highlights an additional element. If we consider particle size obtained at Reynolds numbers 440	
greater than 1000 (i.e., high mixing efficiency), the differences among the mixers are very small for 441	
each MR investigated. In fact, the variation of particle size at each MR is smaller than 40 nm, 442	
suggesting that the effect of the mixer geometry is very low when the highest mixing efficiency is 443	
reached. Moreover, results are very reproducible at high mixing efficiency, on the contrary to what 444	
happens under laminar conditions, where the data from different geometries are more scattered. 445	
In Figure 6, zeta potential is shown as a function of the size for nanocapsules obtained with 446	
different mixers, the FRs and oil-to-copolymer ratios. As it is possible to see no significant 447	
differences are detectable depending on the mixers used, showing that both nanocapsules and 448	
nanospheres present the same superficial properties independently on the mixer used, small 449	
differences seem to exist between nanocapsules and nanospheres, but no significant differences are 450	
noted among nanocapsules obtained at different MR. The fact that the presence of the oil does not 451	
impact the final zeta potential value of nanocapsules could be interpreted as a proof of the fact that 452	
the oil stays inside the copolymer shell. This hypothesis is supported by preliminary experimental 453	
evidences obtained with X-ray photoelectron spectroscopy28 and will be reported in future 454	
communications. 455	
As previously mentioned, the copolymer concentration was also varied, keeping constant the oil 456	
concentration. Experiments were performed only in CIJM-d1 with and without quenching and all 457	
the previous trends were confirmed, as shown in Figure 7 where the data are plotted versus 458	
Reynolds as in previous cases. It may be noted that at low polymer concentration, the size of the 459	
nanocapsules measured becomes extremely large, and it is evident that the situation must be 460	
different from the other cases, where a proportional variation of the polymer had a relatively small 461	
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effect. Probably, under these conditions, the polymer quantity available for the formation of the 462	
copolymer shell is too small, and the forming nanocapsules collapse; further work will be necessary 463	
to investigate what happens under these limiting conditions. 464	
Figure 8 shows results for nanocapsules obtained with CIJM-d1 for different initial oil and 465	
copolymer concentrations, but at the same relative MR to investigate the role of the total 466	
concentration of both copolymer and oil. 467	
Results confirm that the copolymer concentration can play also an important role in the final 468	
nanocapsule size, as it stabilizes oily drops and prevent further coalescence. In particular, they 469	
clearly show that at MR lower than one, the total concentration of polymer and oil is not important, 470	
but it is their MR that determines the final size, indicating that the copolymer is able to block oily 471	
drops growth by surrounding them; at higher MRs, results depend on the polymer concentration. As 472	
already mentioned, working at high mixing intensity (Reynolds numbers greater than 1000) the 473	
mean particle size is, on average, between 170 and 280 nm, depending on the mixer and on the MR. 474	
The only data point which does not fall within this range was obtained at MR 2.37 with a 475	
copolymer concentration of 3.2 mg/mL and oil concentration of 8 µL/mL. This data set shows a 476	
mean particle size drastically larger than that for samples obtained under similar operating 477	
conditions, even in case of quench; the relative increase observed for nonquenched particles, then, 478	
is very relevant. Moreover, the solubility data already discussed show that there is a copolymer 479	
amount remaining in the solution (0.2 g/L in acetone–water mixture at 90% of water) that has to be 480	
subtracted from the initial copolymer concentration to give the effective available copolymer 481	
amount. This is naturally more important at low initial copolymer concentrations, as in the case of 482	
3.2 mg/mL. 483	
To conclude, this second data set shows that increasing the copolymer amount, nanocapsule size 484	
decreases and probably copolymer wall thickness increases. Quenching is useful in stabilizing the 485	
system, preventing further aggregation especially when the copolymer amount is lower (and 486	
probably the copolymer wall is thinner), but below a certain polymer concentration, nanocapsules 487	
of controlled size cannot be obtained; the limit conditions, that probably depend on residual 488	
polymer solubility in the liquid mixture, and on process yields, require further investigation. 489	
 490	
CONCLUSIONS 491	
We synthesized a PEGylated cyanoacrylate amphiphilic copolymer, in order to prepare 492	
nanocapsules for pharmaceutical applications. PEGylated copolymers are very useful in the 493	
pharmaceutical field as they increase the blood lifetime of particulate carriers. At the same time, 494	
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they are advantageous as they act as stabilizers, allowing to work without additional stabilizing 495	
agents, thus reducing the costs and avoiding possible toxicity problems. 496	
Nanocapsules were prepared for the first time using CIJMs. These devices provide good mixing and 497	
were already used for obtaining nanoparticles of different materials. The mechanisms involved in 498	
nanocapsule formation inside these devices are still not completely clear, as nanocapsules are a 499	
complex system with more variables involved. The influence of mixer geometry on nanocapsule 500	
formation needs more investigation, especially to understand how the overall mixing time affects 501	
the final nanocapsule size and copolymer distributions. 502	
The results reported in this work demonstrate that CIJMs can be successfully used in nanocapsule 503	
production and represent possibility route for their continuous production. Different types of 504	
nanoparticles are now reaching the clinical trial level; therefore, a continuous route for producing 505	
them with reproducible characteristics is highly desirable. 506	
Further investigations on the pharmaceutical properties of nanoparticles produced by this way are 507	
required, in order to give a complete evaluation of the product and of the system together with the 508	
limiting operating conditions that allow to obtain stable nanocapsules. 509	
 510	
511	
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Table 1. Geometrical details of the CIJMs used for the experiments. 589	
	590	
	591	
 592	
Table 2. Polymer Solubility at Different Composition of the Water–Acetone Mixture 593	
594	
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	596	
Figure 1. Sketch of the CIJMs used in this work. 597	
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Figure 2. Mean particle size (bottom) and zeta potential (top) versus the flow rate for nanocapsules obtained 601	
without quenching water (left, open symbols) and with quenching water (right, filled symbols) for different 602	
mixers: scale down (r ,p ),CIJM-d1 (o ,n ) and scale up (¯ ,¿ ).Experiments at constant polymer (6 mg/mL) 603	
and oil (8 µL/mL) concentration (MR = 1.26). 604	
 605	
606	
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	607	
Figure 3. Mean particle size versus the inlet stream velocity for nanocapsules obtained with different CIJMs: 608	
scale-down mixer (▴), CIJM-d1 mixer (▪), scale-up mixer (♦), and CIJM-d2 mixer (•). Experiments at constant 609	
polymer (6 mg/mL) and oil (8 µL/mL) concentration (MR = 1.26). 610	
 611	
612	
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	614	
Figure 4. Mean particle size versus the jet Reynolds number for nanocapsules obtained without quenching water 615	
(top, open symbols) and with quenching water (bottom, filled symbols) for CIJMs characterized by different 616	
inlet pipes and same mixing chamber: CIJM-d1 (□,▪), CIJM-d2 (○,•). Experiments at constant polymer (6 617	
mg/mL) and oil (8 µL/mL) concentration (MR = 1.26). 618	
 619	
	620	
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	622	
Figure 5. Mean particle size versus the jet Reynolds number for nanocapsules and nanospheres obtained at four 623	
different oil-to-copolymer mass ratios, MR = 0 (⋄ ,♦), MR = 0.76 (□,▪), MR = 1.26 (○,•), and MR = 2.37 (▵ ,▴) 624	
without quenching (left, open symbols) and with quenching (right, filled symbols) for (from top to bottom) scale-625	
down, CIJM-d1, scale-up, and CIJM-d2. Constant polymer concentration (6 mg/mL). 626	
 627	
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	629	
Figure 6. Zeta potential as a function of particle size obtained with different mixers: scale-down (triangle), 630	
CIJM-d1 (square), and scale-up (rhomb). Top graph: particles without quenching. Bottom graph: particles with 631	
quenching. Both nanospheres and nanocapsules are present: nanospheres (black), nanocapsules at MR = 0.76 632	
(half black), nanocapsules at MR = 1.26 (light gray), and nanocapsules at MR = 2.37 (white). 633	
 634	
 635	
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	637	
Figure 7. Mean particle size versus the jet Reynolds number for nanocapsules obtained at constant oil 638	
concentration (8 µL/mL) and at copolymer concentration of 10 mg/mL (MR = 0.76, □,▪), 6 mg/mL (MR = 1.26, 639	
○,•), and 3.2 mg/mL (MR = 2.37, ▵ ,▴) in CIJM-d1 without quenching (open symbols) and with quenching (filled 640	
symbols). 641	
642	
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 643	
Figure 8. Mean particle size versus the jet Reynolds number for nanocapsules obtained with CIJM-d1 without 644	
quenching (open symbol) and with quenching (filled symbol) at two different constant oil-to-copolymer mass 645	
ratio for different copolymer and oil concentrations; upper graph: MR = 0.76 with 4 mg/mL copolymer and 3.2 646	
µL/mL oil (□,▪), 6 mg/mL copolymer and 4.8 µL/mL oil (○,•), 10 mg/mL copolymer, and 8 µL/mL oil ( , ); 647	
lower graph: MR = 2.37 with 3.2 mg/mL copolymer and 8 µL/mL oil (□,▪,–-–), 6 mg/mL copolymer, and 15 648	
µL/mL oil (○,•, ——). 649	
	650	
